Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2
Clinical trial NCT06920199 · RECRUITING
Trial details
- NCT number
- NCT06920199
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-14
- Primary completion
- 2027-05-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.